A detailed history of Koss Olinger Consulting, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Koss Olinger Consulting, LLC holds 531 shares of TMO stock, worth $277,001. This represents 0.03% of its overall portfolio holdings.

Number of Shares
531
Previous 531 -0.0%
Holding current value
$277,001
Previous $293,000 11.95%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$541.52 - $599.02 $287,547 - $318,079
531 New
531 $293,000
Q4 2023

Feb 13, 2024

BUY
$431.41 - $532.94 $4,745 - $5,862
11 Added 1.95%
576 $305,000
Q3 2023

Oct 10, 2023

SELL
$498.29 - $574.41 $4,982 - $5,744
-10 Reduced 1.74%
565 $285,000
Q1 2023

May 12, 2023

SELL
$535.0 - $604.82 $2,140 - $2,419
-4 Reduced 0.69%
575 $331,000
Q4 2022

Feb 13, 2023

SELL
$484.71 - $571.37 $10,663 - $12,570
-22 Reduced 3.66%
579 $318,000
Q3 2022

Nov 14, 2022

BUY
$507.19 - $604.49 $43,111 - $51,381
85 Added 16.47%
601 $305,000
Q2 2022

Jul 08, 2022

SELL
$500.9 - $612.21 $38,569 - $47,140
-77 Reduced 12.98%
516 $280,000
Q1 2022

May 06, 2022

SELL
$524.0 - $644.92 $52,924 - $65,136
-101 Reduced 14.55%
593 $350,000
Q4 2021

Feb 07, 2022

SELL
$569.0 - $667.24 $33,002 - $38,699
-58 Reduced 7.71%
694 $463,000
Q3 2021

Nov 09, 2021

SELL
$509.53 - $609.78 $24,457 - $29,269
-48 Reduced 6.0%
752 $430,000
Q2 2021

Aug 11, 2021

BUY
$441.0 - $508.24 $23,373 - $26,936
53 Added 7.1%
800 $404,000
Q1 2021

May 14, 2021

BUY
$439.85 - $518.83 $328,567 - $387,566
747 New
747 $341,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $204B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Koss Olinger Consulting, LLC Portfolio

Follow Koss Olinger Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koss Olinger Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Koss Olinger Consulting, LLC with notifications on news.